| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: CPIX |
| Security Type |
Common Stock |
| Lead Underwriter |
UBS Investment Bank Jefferies & Co Inc Wells Fargo Bank NA |
| Days In Registration |
633 |
| Date Filed |
16-Nov-2007 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Cumberland Pharmaceuticals Inc, located in Nashville, Tennessee, provides research and development services and markets pharmaceutical products. The company was founded in 1999. |
| Revenue |
$42.6M |
| Net Income |
$3.9M |
| Shares Outstanding (post-offering) |
17.09M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
6.25M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
6.25M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
750.0K |
| File Amount |
$93.75M |
| File Price Range |
$16.00 - $14.00 |
| File Mid Price |
$15.00 |
Current Filing Information
(Amended 29-Aug-2007) |
|
US |
|
Shares Filed |
6.25M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
6.25M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$125.0M |
| · % Change from Original |
33.33 |
| File Price Range |
$21.00 - $19.00 |
| File Mid Price |
$20.00 |
|
